Sifalimumab (MEDI-545) is a monoclonal antibody that targets IFNalpha and suppresses abnormal immune activity by binding to interferon-alpha.Sifalimumab is used for the treatment of moderate to severe SLE.
CAS Number:
[1006877-41-3]
Target:
COX
* VAT and and shipping costs not included. Errors and price changes excepted